Skip to main content

Drug Interactions between influenza virus vaccine, live and Kapectolin (New Formula)

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Major

bismuth subsalicylate influenza virus vaccine, live

Applies to: Kapectolin (New Formula) (bismuth subsalicylate) and influenza virus vaccine, live

CONTRAINDICATED: In pediatric patients, use of live influenza virus vaccine during salicylate or salicylate-containing therapy may pose a theoretical risk of Reye's syndrome based on known association of the syndrome with aspirin and wild-type influenza infection.

MANAGEMENT: The use of live influenza virus vaccine is contraindicated in children and adolescents less than 18 years of age who are receiving salicylate or salicylate-containing therapy. These patients should be immunized with an inactivated influenza virus vaccine.

References (2)
  1. (2022) "Product Information. FluMist (influenza virus vaccine, live)." Medimmune Inc
  2. (2022) "Product Information. Influenza Virus Vaccine, H1N1, Live (influenza virus vaccine, H1N1, live)." Medimmune Inc

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer